Kang, Dan http://orcid.org/0009-0001-8254-3417
Lei, Cheng http://orcid.org/0000-0003-1311-515X
Zhang, Yong http://orcid.org/0009-0009-4733-3084
Wei, Xing http://orcid.org/0000-0002-3035-5633
Dai, Wei http://orcid.org/0000-0003-1650-1590
Xu, Wei http://orcid.org/0000-0002-7769-9601
Zhang, Jingyu http://orcid.org/0000-0002-5057-5553
Yu, Qingsong http://orcid.org/0000-0001-6142-3339
Su, Xueyao http://orcid.org/0000-0002-8398-8709
Huang, Yanyan http://orcid.org/0000-0001-8878-6180
Shi, Qiuling http://orcid.org/0000-0003-0660-3809
Funding for this research was provided by:
National Key R&D Plan for Intergovernmental Cooperation, the Ministry of Science and Technology of China (2022YFE0133100)
Natural Science Foundation of Chongqing, China (CSTB2022NSCQ-MSX0118)
Supported by Beijing Xisike Clinical Oncology Research Foundation (Y-2019AZMS-0486)
Article History
Received: 30 January 2024
Accepted: 14 June 2024
First Online: 27 June 2024
Declarations
:
: All participants provided informed consent. This cohort study has been approved by the Ethics Committee for Medical Research and New Medical Technology of Sichuan Cancer Hospital (No. SCCHEC-02-2018-043).
: We solemnly confirm that the authors have consented to publication.
: The authors declare no competing interests.